首页|ω-3鱼油脂肪乳用于胃癌根治切除术后全胃肠外营养患者的临床研究

ω-3鱼油脂肪乳用于胃癌根治切除术后全胃肠外营养患者的临床研究

扫码查看
目的 探究ω-3鱼油脂肪乳在胃癌根治切除术后全胃肠外营养(TPN)中的应用效果.方法 行根治切除术的胃癌患者分为对照组和试验组.对照组患者术后应用TPN,能量主要为葡萄糖和常规脂肪乳,每日热卡供给为100~125 kJ·kg-1,深静脉置管滴注10~12 h;试验组患者在对照组治疗的基础上,添加ω-3鱼油脂肪乳100 mL,每日热卡供给及输注条件同对照组,2组均治疗7 d.比较2组患者临床疗效,患者营养状况(总蛋白、转铁蛋白、白蛋白和氮平衡)、胃肠功能恢复情况、免疫功能[CD4+/CD8+和自然杀伤(NK)细胞]、腹腔引流液炎症因子[白细胞介素-6(IL-6)、IL-12p70、肿瘤坏死因子-α(TNF-α)]水平,并进行安全性评价.结果 试验组和对照组分别纳入40和42例.治疗后,试验组和对照组的总有效率分别为90.00%(36例/40例)和71.43%(30例/42例),在统计学上差异有统计学意义(P<0.05).2组患者总蛋白、转铁蛋白和白蛋白在术后3 d均降低,但在术后7 d升高,氮平衡在术后升高;但2组各时间段总蛋白、转铁蛋白、白蛋白和氮平衡的比较,在统计学上差异均无统计学意义(均P>0.05).试验组与对照组首次排气时间分别为(55.72±9.75)和(61.52±10.43)h,试验组与对照组术后7 d外周血CD4+/CD8+分别为1.50±0.38 和 1.29±0.30,NK 细胞比例分别为(19.64±3.04)%和(17.24±2.96)%,引流液中 IL-6 水平分别为(18.77±4.69)和(32.36±5.18)pg·mL-1,IL-12p70分别 为(6.14±1.86)和(8.93±2.17)pg·mL-1,TNF-α 分别为(25.62±4.95)和(30.75±4.88)pg·mL-1,试验组的上述指标与对照组比较,在统计学上差异均有统计学意义(均P<0.05).治疗期间,试验组的药物不良反应主要有呕吐、恶心、持续腹胀,对照组的药物不良反应主要有呕吐、恶心、持续腹胀.试验组和对照组的总药物不良反应发生率分别为20.00%和26.19%,在统计学上差异无统计学意义(P>0.05).结论 ω-3鱼油脂肪乳可提升胃癌患者术后免疫功能,降低炎症反应,减少腹腔引流量,促进术后康复.
Clinical trial on the use of ω-3 fish oil fat milk in the treatment of total parenteral nutrition after radical resection of gastric cancer
Objective To explore the application effect of ω-3 fish oil fat emulsion in total parenteral nutrition(TPN)after radical resection of gastric cancer.Methods Patients with gastric cancer undergoing radical resection in the hospital were divided into control group and treatment group.The patients in the control group were treated with TPN after operation,and the energy was mainly glucose and conventional fat emulsion.The daily calorie supply was 100-125 kJ·kg-1,and the deep venous catheter was dripped for 10-12 h.On the basis of the control group,the patients in the treatment group were added with ω-3 fish oil fat emulsion 100 mL,and the daily calorie supply and infusion conditions were the same as those in the control group.Both groups were treated for 7 days.All patients were treated for 7 d.The nutritional status(total protein,transferrin,albumin,nitrogen balance),gastrointestinal function recovery,immune function[CD4+/CD8+,natural killer(NK)cells],inflammatory factors[interleukin-6(IL-6),IL-12p70,tumor necrosis factor-α(TNF-α)]in abdominal drainage fluid and the safety was evaluated.Results There were 40 cases in treatment group and 42 cases in control group,respectively.After treatment,total response rates in treatment group and control group were 90.00%(36 cases/40 cases)and 71.43%(30 cases/42 cases),and the difference was statistically significant(P<0.05).In the two groups,total protein,transferrin and albumin decreased at 3 d after surgery,but they all increased at 7 d after surgery,and nitrogen balance increased after surgery.There was no significant difference in total protein,transferrin,albumin or nitrogen balance between the two groups at different time periods(all P>0.05).The first exhaust time in treatment group and control group were(55.72±9.75)and(61.52±10.43)h.At 7 d after surgery,proportions of peripheral blood CD4+/CD8+levels in treatment group and control group were 1.50±0.38 and 1.29±0.30;proportions of NK cells were(19.64±3.04)%and(17.24±2.96)%;IL-6 levels in drainage fluid were(18.77±4.69)and(32.36±5.18)pg·mL-1;IL-12p70 levels were(6.14±1.86)and(8.93±2.17)pg·mL-1;TNF-α levels were(25.62±4.95)and(30.75±4.88)pg·mL-1,the differences were statistically significant(all P<0.05).During treatment,main adverse drug reactions included vomiting,nausea and persistent abdominal distension in treatment group,while main adverse drug reactions included vomiting,nausea and persistent abdominal distension in control group.There was no significant difference in total incidence of adverse drug reactions between treatment group and control group(20.00%vs 26.19%,P>0.05).Conclusion ω-3 fish oil fat emulsion can enhance immune function,reduce inflammatory response,abdominal drainage volume and promote postoperative rehabilitation in patients with gastric cancer.

ω-3 fish oil fat emulsiongastric cancertotal parenteral nutritionimmune functioninflammatory responseabdominal drainage fluid

徐雁、余晓婷、尹帅

展开 >

杭州市肿瘤医院 重症医学科,浙江 杭州 310002

ω-3鱼油脂肪乳 胃癌 全胃肠外营养 免疫功能 炎症反应 腹腔引流液

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(18)
  • 10